Danielle Denise Whritenour

About Danielle Denise Whritenour

National award-winning Specialty Pharma leader with 20 years of experience driving regional brand strategy, KOL engagement, launch readiness, and cross-functional execution across complex rare disease, oncology/hematology markets. I specialize in leading field-based marketing strategy within highly coordinated ecosystems, including academic centers of excellence, transplant centers, and key community oncology networks—closely aligning with Medical, Sales, and Market Access to accelerate adoption of innovative therapies.In my roles, I’ve led successful commercialization and launch integration for 18+ novel therapies across sales teams, including targeted therapies, immunotherapies, and precision medicine platforms. I am recognized for building trusted partnerships with Medical Experts (MEs) and • Developing and executing regional brand strategy• Driving HCP and Medical Expert advocacy• Leading field insights → HQ integration for brand planning• Supporting congress strategy, speaker training, and advisory boards• Coaching field teams on customer engagement and value-based tactics• Strengthening influence across cross-brand and cross-indication portfoliosKey strengths • Leading regional brand execution across priority accounts, transplant sites, and COEs• Driving KOL/MEA engagement and strengthening medical advocacy for multiple indications and brands• Collaborating with Sales, Access, and Medical to orchestrate aligned field strategy• Delivering field insights to HQ to influence brand planning, messaging, and resource development• Supporting congress strategy, advisory boards, and speaker program excellence• Driving omnichannel pull-through and adoption of scientific and value-based resources• Educating clinical and admin stakeholders on reimbursement pathways, buy-and-bill, distribution models, and access considerations My therapeutic background includes radioligand therapy, precision medicine, precision oncology, hematology, solid tumors, immunology, rare disease, nephrology, targeted therapies, biosimilars, and specialty infusion/injectables with a deep understanding of reimbursement, access barriers, value frameworks, and patient support pathways across the Southeast Passionate about advancing life-changing therapies by elevating HCP engagement, informing brand strategy with real-world insights, strengthening collaboration between field teams and headquarters, elevating patient outcomes through strategic field execution, collaborative leadership, and meaningful engagement with medical experts and centers of excellence.

Experience

1. Associate Director Priority Accounts, Radioligand Therapy Florida

   Novartis

   Feb 2026 — Present · FL, US

   Champion institutional advocacy for the adoption of the Radioligand Therapies (RLT) and Neuroendocrine Tumors (NET) brand to support appropriate product utilization. Build strong partnerships with Neuroendocrine Tumors (NET) Centers of Excellence and health care sites to drive impactful engagement. Lead commercial strategic strategy and foster strong relationships with senior stakeholders to drive Radioligand Therapy (RLT) adoption at scale. Develop, coordinate, and execute strategic business plans for priority accounts, ensuring alignment with market dynamics and organizational goals. Cultivate relationships with clinical, operational, and administrative decision-makers to streamline care pathways, treatment protocols, and workflow solutions. Stay informed on market trends, customer economics, and access models, including payment programs and reimbursement strategies. Conduct periodic needs assessments to identify opportunities and communicate actionable insights to cross-functional partners. Support cross-functional commercial team in diagnosing business challenges and implementing strategies that optimize outcomes for Radioligand Therapies and Neuroendocrine Tumors accounts and affiliated health systems.

Education

• Florida State University

  Bachelor of Science - BS, Nutrition Science

• Florida State University

  Master of Business Administration - MBA, Finance

• University of Florida

  College of Pharmacy- Master Certificate-Precision Medicine & Pharmacogenomics, Pharmacoeconomics/Pharmaceutical Economics